Kurt Gish, Ph.D., Joins BioLoomics as Chief Scientific Officer
Key Highlights Dr. Kurt Gish joins BioLoomics as Chief Scientific Officer. Focus on building pipeline of lysosomal targeting…
Browsing Tag
Trilo Therapeutics
1 post